CHG-2023-0134

Facility Change for Glucovantib. Formulation Change for Glucovantib — major revision. Impacts 3 markets and 1 variations.

Change Number
CHG-2023-0134
Type
Facility Change
Product
Glucovantib
Status
Active
Owner
Marcus Webb
Initiated
2022-02-06
Description

Formulation Change for Glucovantib — major revision

Impacted Markets (3)
CH — SwitzerlandDE — GermanySA — Saudi Arabia
Impacted Modules
3.2.P5.3.54.2.12.3.P
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved